Paper18924115
Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma.
Schreck S and 6 others. Hematol Oncol, 2009. Cited by 129 papers, by iCite.
Cite this record
ConductScience Library. Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma. Papers, record 18924115. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/18924115
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Prognostic impact of tumour-infiltrating Th2 and regulatory T cells in classical Hodgkin lymphoma.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hodgkin Disease | Major topic |
| Lymphocytes, Tumor-Infiltrating | Major topic |
| T-Lymphocytes, Regulatory | Major topic |
| Th1 Cells | Major topic |
| Animals | |
| Antibody Specificity | |
| Disease-Free Survival | |
| Forkhead Transcription Factors | |
| Humans | |
| Immunohistochemistry | |
| Prognosis | |
| Proto-Oncogene Proteins c-maf | |
| Survivors | |
| T-Box Domain Proteins | |
| T-bet Transcription Factor |
Source PubMed
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 129 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42074324 | The Hodgkin Lymphoma Microenvironment: Insights from Spatial Transcriptomics. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42074324 | PubMed |
| 41813615 | A Link Between Allergy and Hematological Malignancies? Focus on Possible Mechanisms and the Potential Role of Biological Therapies. | Clin Transl Allergy | 2026 | https://conductscience.org/library/papers/41813615 | PubMed |
| 40941026 | Hodgkin Lymphoma Classification-From Historical Concepts to Current Refinements. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40941026 | PubMed |
| 39642846 | Tumor-Infiltrating Immune Cells in Colorectal Cancer. | Neoplasia | 2025 | https://conductscience.org/library/papers/39642846 | PubMed |
| 39465401 | Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies? | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39465401 | PubMed |
| 38680717 | Lymphocyte Level at Diagnosis in Hodgkin lymphoma: Could It be an Indicator of the Stage at Initial Diagnosis? | Int J Hematol Oncol Stem Cell Res | 2024 | https://conductscience.org/library/papers/38680717 | PubMed |
| 38672668 | Th2 Cells Are Associated with Tumor Recurrence Following Radiation. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38672668 | PubMed |
| 38398216 | Baseline IgM Amounts Can Identify Patients with Poor Outcomes: Results from a Real-Life Single-Center Study on Classical Hodgkin Lymphoma. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38398216 | PubMed |
| 38328613 | Distinct T helper cell-mediated antitumor immunity: T helper 2 cells in focus. | Cancer Pathog Ther | 2023 | https://conductscience.org/library/papers/38328613 | PubMed |
| 38148013 | Evidence for distinct mechanisms of immune suppression in EBV-positive and EBV-negative Hodgkin lymphoma. | J Clin Exp Hematop | 2023 | https://conductscience.org/library/papers/38148013 | PubMed |
| 37452117 | The prognostic and biology of tumour-infiltrating lymphocytes in the immunotherapy of cancer. | Br J Cancer | 2023 | https://conductscience.org/library/papers/37452117 | PubMed |
| 37372147 | Unraveling the Immune Microenvironment in Classic Hodgkin Lymphoma: Prognostic and Therapeutic Implications. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37372147 | PubMed |
| 36980536 | Role and Potential of Different T Helper Cell Subsets in Adoptive Cell Therapy. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36980536 | PubMed |
| 36900230 | A Phase 2 Trial of Ibrutinib and Nivolumab in Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/36900230 | PubMed |
| 36405691 | Vessel state and immune infiltration of the angiogenesis subgroup and construction of a prediction model in osteosarcoma. | Front Immunol | 2022 | https://conductscience.org/library/papers/36405691 | PubMed |
| 36325271 | Immune Biomarkers in the Peripheral Blood and Tumor Microenvironment of Classical Hodgkin Lymphoma Patients in Relation to Tumor Burden and Response to Treatment. | Hemasphere | 2022 | https://conductscience.org/library/papers/36325271 | PubMed |
| 36311750 | Immune-infiltrating signature-based classification reveals CD103+CD39+ T cells associate with colorectal cancer prognosis and response to immunotherapy. | Front Immunol | 2022 | https://conductscience.org/library/papers/36311750 | PubMed |
| 36230815 | Histological Subtypes Drive Distinct Prognostic Immune Signatures in Classical Hodgkin Lymphoma. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36230815 | PubMed |
| 35267668 | The Hodgkin Lymphoma Immune Microenvironment: Turning Bad News into Good. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35267668 | PubMed |
| 35095898 | Tumor-Infiltrating Lymphocytes in Colorectal Cancer: The Fundamental Indication and Application on Immunotherapy. | Front Immunol | 2021 | https://conductscience.org/library/papers/35095898 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| FOXP3 | 50943 | PubTator's text mining | https://conductscience.org/library/genes/50943 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/18924115
GET https://conductscience.org/api/papers/v1/18924115/cited_by?page=2